ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LLOY Lloyds Banking Group Plc

55.54
-0.14 (-0.25%)
25 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Lloyds Banking Group Plc LSE:LLOY London Ordinary Share GB0008706128 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.14 -0.25% 55.54 55.56 55.58 55.90 55.36 55.76 110,162,121 16:35:25
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Commercial Banks, Nec 23.74B 5.46B 0.0859 6.47 35.32B
Lloyds Banking Group Plc is listed in the Commercial Banks sector of the London Stock Exchange with ticker LLOY. The last closing price for Lloyds Banking was 55.68p. Over the last year, Lloyds Banking shares have traded in a share price range of 39.55p to 57.22p.

Lloyds Banking currently has 63,569,225,662 shares in issue. The market capitalisation of Lloyds Banking is £35.32 billion. Lloyds Banking has a price to earnings ratio (PE ratio) of 6.47.

Lloyds Banking Share Discussion Threads

Showing 308476 to 308494 of 429200 messages
Chat Pages: Latest  12344  12343  12342  12341  12340  12339  12338  12337  12336  12335  12334  12333  Older
DateSubjectAuthorDiscuss
08/4/2020
08:51
More debt defaults coming PC..
9th default by Argies.
Why we continue lending to people who regularly default beggars belief.

crossing_the_rubicon
08/4/2020
08:51
Argentina $10bn debt default the other day may not be an isolated case.
patientcapital
08/4/2020
08:47
As an aside, just because someone works for a Pharmaceutical company doesnt mean they know anything about the pathology of viruses etc.

After all, plenty of people who work in Finance havent a clue about Finance. As ample evidence before us in the current markets evidences.

Attempting to solve a debt crisis by taking on even more debt!

And look where we are.

In even bigger trouble than 2007/2008

crossing_the_rubicon
08/4/2020
08:46
well, it did come from the guardian, i think that paper is just about one step up from the Beano,
aljm
08/4/2020
08:46
CTR...
Brilliant answer to Ace. LMAO :o)

maxidi
08/4/2020
08:44
Fears are growing of a crisis in the UK’s £75bn car loan market, where 6.5m vehicles have been financed through leasing deals with monthly payments that are already proving unaffordable for some laid-off as a result of the coronavirus. The Finance and Leasing Association (FLA), which represents the credit arms of the car manufacturers as well as the banks, said: “It’s early days in terms of quantifying the impact on arrears, but the number of forbearance requests has grown significantly in recent weeks.” – Guardian

"Oh dear next bubble set to burst"

crossing_the_rubicon
08/4/2020
08:06
Good find stonedyou.
cheshire pete
08/4/2020
07:54
Cure found for COVID-19 with a single dose of an already FDA approved drug?
University of Melbourne and Royal Melbourne Hospital pushes for human trial and funding


Juergen T SteinmetzApril 8, 2020 04:19


A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with

the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint

venture of the University of Melbourne and Royal Melbourne Hospital, has shown

that an anti-parasitic drug already available around the world kills the virus

within 48 hours.


Although several clinical trials are now underway to test possible therapies, the

worldwide response to the COVID-19 outbreak has been largely limited to

monitoring/containment. Ivermectin, an FDA-approved anti-parasitic previously

shown to have broad-19 spectrum anti-viral activity in vitro, is an inhibitor of

the causative virus.

The use of Ivermectin to combat COVID-19 depends on pre-clinical testing and

clinical trials, with funding urgently required to progress the work.

In Australia, a Monash University-led collaborative study was published in

Antiviral Research, a peer-reviewed medical journal



The Monash Biomedicine Discovery Institute’s Dr Kylie Wagstaff, who led the study,

said the scientists showed that the drug, Ivermectin, stopped the SARS-CoV-2 virus

growing in cell culture within 48 hours.

“We found that even a single dose could essentially remove all viral RNA by 48

hours and that even at 24 hours there was a really significant reduction in it,”

Dr Wagstaff said.

Ivermectin is an FDA-approved anti-parasitic drug that has also been shown to be

effective in vitro against a broad range of viruses including HIV, Dengue,

Influenza and Zika virus.

Dr Wagstaff cautioned that the tests conducted in the study were in vitro and that

trials needed to be carried out in people.
________________________________________

“Ivermectin is very widely used and seen as a safe drug. We need to figure out now

whether the dosage you can use it in humans will be effective – that’s the next

step,” Dr Wagstaff said.

“In times when we’re having a global pandemic and there isn’t an approved

treatment, if we had a compound that was already available around the world then

that might help people sooner. Realistically it’s going to be a while before a

vaccine is broadly available.

Although the mechanism by which Ivermectin works on the virus is not known, it is

likely, based on its action in other viruses, that it works to stop the

virus ‘dampening down’ the host cells’ ability to clear it, Dr Wagstaff said.

Royal Melbourne Hospital’s Dr Leon Caly, a Senior Medical Scientist at the

Victorian Infectious Diseases Reference Laboratory (VIDRL) at the Doherty

Institute where the experiments with live coronavirus were conducted, is the

study’s first author.

“As the virologist who was part of the team who were first to isolate and share

SARS-COV2 outside of China in January 2020, I am excited about the prospect of

Ivermectin being used as a potential drug against COVID-19,” Dr Caly said.

stonedyou
08/4/2020
07:53
Cure found for COVID-19 with a single dose of an already FDA approved drug?
University of Melbourne and Royal Melbourne Hospital pushes for human trial and funding


Juergen T SteinmetzApril 8, 2020 04:19


A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with

the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint

venture of the University of Melbourne and Royal Melbourne Hospital, has shown

that an anti-parasitic drug already available around the world kills the virus

within 48 hours.


Although several clinical trials are now underway to test possible therapies, the

worldwide response to the COVID-19 outbreak has been largely limited to

monitoring/containment. Ivermectin, an FDA-approved anti-parasitic previously

shown to have broad-19 spectrum anti-viral activity in vitro, is an inhibitor of

the causative virus.

The use of Ivermectin to combat COVID-19 depends on pre-clinical testing and

clinical trials, with funding urgently required to progress the work.

In Australia, a Monash University-led collaborative study was published in

Antiviral Research, a peer-reviewed medical journal



The Monash Biomedicine Discovery Institute’s Dr Kylie Wagstaff, who led the study,

said the scientists showed that the drug, Ivermectin, stopped the SARS-CoV-2 virus

growing in cell culture within 48 hours.

“We found that even a single dose could essentially remove all viral RNA by 48

hours and that even at 24 hours there was a really significant reduction in it,”

Dr Wagstaff said.

Ivermectin is an FDA-approved anti-parasitic drug that has also been shown to be

effective in vitro against a broad range of viruses including HIV, Dengue,

Influenza and Zika virus.

Dr Wagstaff cautioned that the tests conducted in the study were in vitro and that

trials needed to be carried out in people.
________________________________________

“Ivermectin is very widely used and seen as a safe drug. We need to figure out now

whether the dosage you can use it in humans will be effective – that’s the next

step,” Dr Wagstaff said.

“In times when we’re having a global pandemic and there isn’t an approved

treatment, if we had a compound that was already available around the world then

that might help people sooner. Realistically it’s going to be a while before a

vaccine is broadly available.

Although the mechanism by which Ivermectin works on the virus is not known, it is

likely, based on its action in other viruses, that it works to stop the

virus ‘dampening down’ the host cells’ ability to clear it, Dr Wagstaff said.

Royal Melbourne Hospital’s Dr Leon Caly, a Senior Medical Scientist at the

Victorian Infectious Diseases Reference Laboratory (VIDRL) at the Doherty

Institute where the experiments with live coronavirus were conducted, is the

study’s first author.

“As the virologist who was part of the team who were first to isolate and share

SARS-COV2 outside of China in January 2020, I am excited about the prospect of

Ivermectin being used as a potential drug against COVID-19,” Dr Caly said.

stonedyou
08/4/2020
07:34
The henchmen of the Left are upset and thoughtless. Such people are incapable of running country. All emotional rant and madness. Never vote Labour. They do not have maturity, compassion or intellect. Remember. Do not forget their nastiness. Never vote Labour.And No Deal
xxxxxy
08/4/2020
07:29
849.Apparently plenty of ventilators in Nottingham.Maybe other reasons for not ventilated.Someone died. Often very bitter and angry.
xxxxxy
08/4/2020
07:22
Mayor Oakes disgusts me.Labour disgusts me.And No Deal.
xxxxxy
08/4/2020
07:11
Boris. Get well soon.Love you.Hero.And NO DEAL
xxxxxy
08/4/2020
07:10
BobPosted April 7, 2020 at 6:49 pm | PermalinkBristol & Weston NHS Foundation Trust is hiring a new 'Diversity and Inclusion Manager'.The salary starts at £44,606 to £50,819 a year.That that could cover the wages of two new nurses.Ill leave that with you Sir John.
xxxxxy
08/4/2020
07:08
Wrong thread. Apologies.
freddie01
08/4/2020
07:01
"Contain, delay and mitigate any outbreak"By JOHNREDWOOD | Published: APRIL 8, 2020These words from Public Health England have framed policy so far. The first phase (Contain)  saw efforts to trace, test and isolate anyone carrying the virus and the people they had met. The second phase (Delay) has seen big efforts to impede the spread of the virus by keeping people apart and keeping them from  places of work as well as from entertainment. The final phase (Mitigate) is to learn to live with the disease, limiting its spreads with sensible precautions  with enough capacity to treat patients who do get it whilst we await vaccinations.Their initial plan played down the extent of the controls needed for the second phase we are now in.  They told us on March 3 that if we got to this stage it would mean "people distancing strategies such as school closures, encouraging greater home working, reducing the number of large social gatherings- whilst ensuring the country's ability to run as normally as possible".  They seemed to move on from  the bit about as near normal as possible when they came to design the detail of the lock down. It emerged it entailed closing all physical shops other than food and medicines, stopping the car and homes markets  and much else besides.  They promised  to "implement a distribution strategy for the UK's stockpiles of key medicines and equipment" . After early issues with inadequate supplies the army was brought in to help and orders stepped up  to business. .The idea of  delaying the virus  was to reduce "the risk of overlapping with seasonal flu and other challenges that the colder months bring". This implies they expected to lift the controls come late Spring and early summer.We now see some other countries deciding to relax their controls progressively  but carefully in the next few weeks. China has done so.  Austria has just set out a timetable starting next week by re opening lots of small shops. Sweden and South Korea have not gone very far in imposing controls in the first place though Sweden is now taking more powers. The issue is what is the trigger to start relaxing the controls? Is it a tailing off in the death rate? A tailing off in the recorded number of new infections? How much value can we place on the numbers for new infections when most people that get it stay at home and are not tested?We do need greater visibility on how this crucial call will be made. Some will argue the controls must go on for longer to avoid a possible second wave. Others will point to the big economic damage delays in getting back to work creates. As there was always a three phase strategy it would at least be good to know what the trigger is for going to the third phase and putting Shut Down  UK behind us.
xxxxxy
08/4/2020
05:06
Buywell the most bullish i have seen on the FTSE.

"buywell calls the FTSE 100 to 45000"

Think he made a mistake with a fat finger lol

bargainbob
08/4/2020
02:45
these Chinese are magicians. they can make things appear and disappear in no time.a bit like Trump actually.
sr2day
08/4/2020
00:14
So what does everybody think she is suffering from. I've been doing lots searching and it seems it has a combination of many mental conditions. That last rant, talking to it itself, without third party provocation suggests there's a bit of schizophrenia in there. What da ya all think
asdb9
Chat Pages: Latest  12344  12343  12342  12341  12340  12339  12338  12337  12336  12335  12334  12333  Older

Your Recent History

Delayed Upgrade Clock